Fort Sheridan Advisors LLC Vista Gen Therapeutics, Inc. Transaction History

Fort Sheridan Advisors LLC

  • $526 Million
  • Q1 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2019

Nov 12, 2019
SELL
$0.46 - $1.29 $6,900 - $19,350
-15,000 Closed
0 $0
Q4 2018

May 13, 2019
BUY
$1.28 - $2.24 $19,200 - $33,600
15,000 New
15,000 $23,000

Others Institutions Holding VTGN

# of Institutions
2
Shares Held
2.7M
Call Options Held
0
Put Options Held
0
View Full List

About VistaGen Therapeutics, Inc.

VTGN Quotes by TradingView
  • Ticker VTGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 206,836,000
  • Market Cap $685M
  • Description
  • VistaGen Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in developing and commercializing various medicines with the potential to care for anxiety, depression, and other disorders of the central nervous system (CNS). The company's CNS pipeline includes PH94B, a rapid-onset neuroactive nasal spray, which is in Phase III d...
More about VTGN
Track This Portfolio

Track Fort Sheridan Advisors LLC Portfolio

Follow Fort Sheridan Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fort Sheridan Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fort Sheridan Advisors LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email